Palle Christophersen - Saniona AB Insider

SANION -- Sweden Stock  

SEK 35.25  0.70  2.03%

Dr. Palle Christophersen, Ph.D. has served as Chief Scientific Officer at Saniona AB since 2014. He is also CoFounder of the Company. He joined NeuroSearch in 1991 as Research Scientist in electrophysiology and served as project manager from 1994, where he developed the NeuroPatch system and discovered Endovion for sickle cell anaemia and cancer. From 20042011, he served as Director of In Vitro Pharmacology, and was in 2006 appointed Vice President and member of the NeuroSearch VP management group. He has authored more than 60 peerreviewed articles and is inventor of more than 60 patents. He is Chief Scientific Officer at Saniona AS. He holds a Doctorate in Philosophy in Physiology from the University of Copenhagen.
Age: 58  Founder Since 2014  Ph.D    
45 70 70 52 25

Management Efficiency

The company has return on total asset (ROA) of (72.84) % which means that it has lost $72.84 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (137.41) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 10 M in total debt with debt to equity ratio (D/E) of 29.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Saniona AB has Current Ratio of 2.2 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Entity Summary

Saniona AB , a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases, and treatment of pain in Denmark. Saniona AB was founded in 2011 and is headquartered in Ballerup, Denmark. Saniona AB operates under Pharmaceuticals And Biosciences classification in Sweden and traded on Stockholm Stock Exchange. It employs 22 people.Saniona AB (SANION) is traded on Stockholm Stock Exchange in Sweden. It is located in Baltorpvej 154 and employs 22 people.

Saniona AB Leadership Team

Carl Sundberg, Independent Director
Leif Andersson, Independent Director
Anker Lundemose, Independent Director
Claus Braestrup, Independent Chairman of the Board
Anna Ljung, Director
Palle Christophersen, Co-Founder and Chief Scientific Officer
deBethizy, Chairman of the Board
Thomas Feldthus, CFO, Executive Vice President
Joergen Drejer, CEO, Director

Stock Performance Indicators

Current Sentiment - SANION

Saniona AB Investor Sentiment

Macroaxis portfolio users are evenly split in their outlook on investing in Saniona AB. What is your outlook on investing in Saniona AB? Are you bullish or bearish?
50% Bullish
50% Bearish
Currently Active Assets on Macroaxis
Purchased over 70 shares of
a day ago
Traded for 35.02
Purchased a lot of shares of
a day ago
Traded for 154.92
Purchased over 20 shares of
a day ago
Traded for 112.14
Purchased over 300 shares of
a day ago
Traded for 9.55
Purchased over 400 shares of
a day ago
Traded for 6.33
Also please take a look at World Market Map. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.